Would glucagon peptide-1 receptor agonists have efficacy in binge eating disorder and bulimia nervosa? A review of the current literature

Binge eating, eating an abnormally large amount of food in a discrete period of time with a sense of loss of control over eating, is a defining feature of the eating disorders binge eating disorder (BED) and bulimia nervosa (BN). Both BED and BN are important public health problems for which there are few medical treatments. However, almost all drugs with central nervous system-mediated weight loss properties studied thus far in randomized, placebo-controlled trials in persons with BED or BN have been efficacious for reducing binge eating behavior.

Source: Medical Hypotheses - January 2, 2018 Category: Biomedical Science Authors: Susan L. McElroy, Nicole Mori, Anna I. Guerdjikova, Paul E. Keck Source Type: research